WCLC 2022 Conference Coverage


 

WCLC 2022 Efficacy of 1L Immune Checkpoint Inhibitors in Advanced NSCLC Harboring KRAS, MET, FGFR, RET, BRAF, and HER2 Alterations

312 views
August 29, 2022
Comments 0
Login to view comments. Click here to Login